ReviewFrontiers in immunology2021

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy.

Hui Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.